EVALUATION OF THE EFFECTIVENESS OF PRETRACHEAL LYMPHOTROPIC ANTIBIOTIC THERAPY IN CHRONIC LUNG DISEASES IN CHILDREN

One of the reasons for the ineffectiveness of antibiotic therapy in chronic lung diseases is the poor permeability of the antibiotic directly to the focus of inflammation in the lung tissue due to pneumosclerotic changes and reduction of pulmonary blood flow. Therefore, it is important to choose a method of therapy that maximizes the focus of inflammation in the lungs with antibacterial drugs.The purpose of this work was an assessment of the effectiveness of pretracheal lymphotropic antibiotic therapy on the state of hemocoagulation in chronic nonspecific lung diseases in children.Materials and methods. We examined 100 sick children with CLD (60 with bronchiectasis and 40 with chronic bronchitis) aged 7 to 15 years in the stage of disease exacerbation. Lymphotropic therapy was carried out by us: pretracheal method. The method of regional lymphotropic antibiotic therapy was proposed by S. U. Dzhumabaev. A comparative study of the effectiveness of RLAT with the traditional intramuscular method made it possible to identify a faster positive clinical dynamics, the elimination of symptoms of exacerbation of CLD.